Disease-carrying mosquitos pack twice the punch

by Sarah Craig

An international team of researchers from the University of Notre Dame's Eck Institute for Global Health and Imperial College London has recently published its work on a malaria-filaria co-transmission model, where the same mosquito transmits both diseases together. Found in large areas of sub-Saharan Africa, one mosquito genus, Anopheles, carries both the malaria parasite Plasmodium falciparum and the microfilarial worm Wuchereria bancrofti, which causes lymphatic filariasis, which can develop into elephantiasis.

According to lead researcher Edwin Michael, professor of biological sciences specializing in epidemiology at the University of Notre Dame, "This has major implications for the transmission of each disease in endemic settings, and, of course, for developing better control interventions that ensure that removal of one disease does not have a profound (a worse ) outcome for diseases caused by the other pathogen."

The manuscript, titled "Modelling Co-Infection with Malaria and Lymphatic Filariasis," is being published in PLOS Computational Biology. The findings indicate that mosquito co-infection is more prevalent than expected from single prevalence, meaning two parasites facilitate each other's invasion. Looking for ways to address co-infection is vital to addressing the considerable public health burden of these major afflicting humans today.

Since these two infections are transmitted by the same mosquito species, important questions about optimal control strategies in co-endemic regions need to be answered. The effect of the presence of each infection on the endemicity of the other leads to the need for comprehensive, reliable and dynamic pathogen co-infection modeling studies.

Michael, who studies the spread and control of tropical infectious diseases, leads the team. Much of his research addresses the next generation of critical questions regarding the population ecology, epidemiology and control of neglected diseases and vector-borne diseases including malaria, dengue and lymphatic filariasis. Team members include Imperial College postdoctoral researcher Hannah Slater and Dr. Manoj Gambhir, both from the Department of Infectious Disease Epidemiology, and Dr. Paul E. Parham, currently at Bangor University in Wales.

Malaria is a mosquito-borne infectious disease in humans and other animals. There are five forms of malaria, which can cause symptoms ranging from a headache to death. More than 1 million people, many of whom are children in Africa, die every year from the . Currently, there is no vaccine for malaria, though researchers around the world, including many at Notre Dame, are working on understanding the complexities and working toward vaccine development.

Filarial worms, which reproduce and occupy the lymphatic system in humans, cause lymphatic filariasis, which can develop into elephantiasis. Early stages can go undetected for years. Once the damage to the lymphatic system is done, it cannot be reversed.

The Eck Institute for Global Health is a University-wide enterprise that recognizes health as a fundamental human right and endeavors to promote research, training and service to advance health standards for all people, especially people in low and middle-income countries, who are disproportionately impacted by preventable diseases.

More information: www.ploscompbiol.org/article/i… bi.1003096#abstract1

add to favorites email to friend print save as pdf

Related Stories

New test better detects elephantiasis worm infection

May 20, 2013

A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...

Malaria's severity reset by mosquito

May 30, 2013

(Medical Xpress)—For the first time, researchers have proven that the way in which malaria is transmitted to the host affects how severe the resulting infection will be.

Stinky feet may lead to better malaria traps

Jun 04, 2013

For decades, health officials have battled malaria with insecticides, bed nets and drugs. Now, scientists say there might be a potent new tool to fight the deadly mosquito-borne disease: the stench of human ...

Recommended for you

Sierra Leone, Liberia brace for new Ebola cases

6 hours ago

Two of the West African nations hardest hit by Ebola were bracing for new caseloads on Monday after trying to outflank the outbreak with a nationwide checkup and a large new clinic.

Reversing the effects of pulmonary fibrosis

6 hours ago

Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

Streets bustling after Sierra Leone shutdown ends

12 hours ago

Streets in Sierra Leone's capital bustled again Monday after an unprecedented nationwide shutdown during which officials said more than 1 million households were checked for Ebola patients and given information ...

User comments